End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
180.2 SAR | -1.53% | -5.75% | +3.33% |
Apr. 22 | Saudi Arabia's National Medical Care Co Declares FY23 Dividend | MT |
Apr. 22 | National Medical Care Wins SAR380 Million Contract for Patient Care Services | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- With a 2024 P/E ratio at 28.16 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.33% | 2.16B | - | ||
-17.07% | 16.85B | B+ | ||
+3.60% | 12.34B | B | ||
+5.64% | 11.77B | B+ | ||
+4.26% | 10.28B | B+ | ||
+25.36% | 8.38B | B | ||
-0.68% | 7.88B | A- | ||
+22.18% | 7.29B | D | ||
+5.77% | 6.75B | B- | ||
+52.00% | 4.69B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4005 Stock
- Ratings National Medical Care Company